Feedback / Questions
EMP-012 - GSK
https://www.gsk.com/en-gb/media/press-releases/gsk-and-empirico-enter-license-agreement-for-clinical-stage-first-in-class-oligonucleotide-candidate/
Oct 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next